BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gautam A, Paudel YN, Abidin S, Bhandari U. Guggulsterone, a farnesoid X receptor antagonist lowers plasma trimethylamine-N-oxide levels: An evidence from in vitro and in vivo studies. Hum Exp Toxicol 2019;38:356-70. [PMID: 30526076 DOI: 10.1177/0960327118817862] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Matsumoto T, Kojima M, Takayanagi K, Taguchi K, Kobayashi T. Role of S-Equol, Indoxyl Sulfate, and Trimethylamine N-Oxide on Vascular Function. Am J Hypertens 2020;33:793-803. [PMID: 32300778 DOI: 10.1093/ajh/hpaa053] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
2 Tang S, Kan J, Sun R, Cai H, Hong J, Jin C, Zong S. Anthocyanins from purple sweet potato alleviate doxorubicin-induced cardiotoxicity in vitro and in vivo. J Food Biochem 2021;:e13869. [PMID: 34287964 DOI: 10.1111/jfbc.13869] [Reference Citation Analysis]
3 Jiang L, Zhang H, Xiao D, Wei H, Chen Y. Farnesoid X receptor (FXR): Structures and ligands. Comput Struct Biotechnol J 2021;19:2148-59. [PMID: 33995909 DOI: 10.1016/j.csbj.2021.04.029] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Iglesias-Carres L, Hughes MD, Steele CN, Ponder MA, Davy KP, Neilson AP. Use of dietary phytochemicals for inhibition of trimethylamine N-oxide formation. J Nutr Biochem 2021;91:108600. [PMID: 33577949 DOI: 10.1016/j.jnutbio.2021.108600] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
5 Yang S, Li X, Yang F, Zhao R, Pan X, Liang J, Tian L, Li X, Liu L, Xing Y, Wu M. Gut Microbiota-Dependent Marker TMAO in Promoting Cardiovascular Disease: Inflammation Mechanism, Clinical Prognostic, and Potential as a Therapeutic Target. Front Pharmacol 2019;10:1360. [PMID: 31803054 DOI: 10.3389/fphar.2019.01360] [Cited by in Crossref: 48] [Cited by in F6Publishing: 49] [Article Influence: 16.0] [Reference Citation Analysis]
6 Lv S, Wang Y, Zhang W, Shang H. Trimethylamine oxide: a potential target for heart failure therapy. Heart 2021:heartjnl-2021-320054. [PMID: 34611047 DOI: 10.1136/heartjnl-2021-320054] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Senesi P, Ferrulli A, Luzi L, Terruzzi I. Diabetes Mellitus and Cardiovascular Diseases: Nutraceutical Interventions Related to Caloric Restriction. Int J Mol Sci 2021;22:7772. [PMID: 34360538 DOI: 10.3390/ijms22157772] [Reference Citation Analysis]
8 Li C, Yang J, Wang Y, Qi Y, Yang W, Li Y. Farnesoid X Receptor Agonists as Therapeutic Target for Cardiometabolic Diseases. Front Pharmacol 2020;11:1247. [PMID: 32982723 DOI: 10.3389/fphar.2020.01247] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
9 Sharma V, Sharma V, Shahjouei S, Li J, Chaudhary D, Khan A, Wolk DM, Zand R, Abedi V. At the Intersection of Gut Microbiome and Stroke: A Systematic Review of the Literature. Front Neurol 2021;12:729399. [PMID: 34630304 DOI: 10.3389/fneur.2021.729399] [Reference Citation Analysis]
10 Girisa S, Parama D, Harsha C, Banik K, Kunnumakkara AB. Potential of guggulsterone, a farnesoid X receptor antagonist, in the prevention and treatment of cancer. Exploration of Targeted Anti-tumor Therapy 2020;1. [DOI: 10.37349/etat.2020.00019] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]